Harold H. Shlevin - Net Worth and Insider Trading
Harold H. Shlevin Net Worth
The estimated net worth of Harold H. Shlevin is at least $0 dollars as of 2024-04-27. Harold H. Shlevin is the COO of Galectin Therapeutics Inc and owns about 0 shares of Galectin Therapeutics Inc (GALT) stock worth over $0. Details can be seen in Harold H. Shlevin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Harold H. Shlevin has not made any transactions after 2018-06-13 and currently still holds the listed stock(s).
Transaction Summary of Harold H. Shlevin
Harold H. Shlevin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harold H. Shlevin owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Harold H. Shlevin’s form 4 insider trades.
Insider Ownership Summary of Harold H. Shlevin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2020-01-09 | director & Chief Executive Officer |
Harold H. Shlevin Latest Holdings Summary
Harold H. Shlevin currently owns a total of 1 stock. Harold H. Shlevin owns 0 shares of Galectin Therapeutics Inc (GALT) as of June 13, 2018, with a value of $0.
Latest Holdings of Harold H. Shlevin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2018-06-13 | 0 | 3.45 | 0 |
Holding Weightings of Harold H. Shlevin
Harold H. Shlevin Form 4 Trading Tracker
According to the SEC Form 4 filings, Harold H. Shlevin has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the sale of 43,698 shares on June 13, 2018, which brought Harold H. Shlevin around $323,802.
Insider Trading History of Harold H. Shlevin
- 1
Harold H. Shlevin Trading Performance
GuruFocus tracks the stock performance after each of Harold H. Shlevin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harold H. Shlevin is 162.03%. GuruFocus also compares Harold H. Shlevin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harold H. Shlevin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harold H. Shlevin's insider trading performs compared to the benchmark.
Performance of Harold H. Shlevin
Average Return
-20.68%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.19 | 162.03 | 90.68 | -20.68 | -36.49 | -45.19 |
| Relative Return to S&P 500(%) | 30.12 | 159.28 | 85.86 | -35.21 | -44.33 | -51.98 |
Harold H. Shlevin Ownership Network
Ownership Network List of Harold H. Shlevin
Ownership Network Relation of Harold H. Shlevin
Harold H. Shlevin Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Harold H. Shlevin is the director & Chief Executive Officer of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Harold H. Shlevin made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 12,500 shares made by Kevin D Freeman , and a net sale of 25,000 shares made by James C Czirr .
In summary, during the past 3 months, insiders sold 25,000 shares of Galectin Therapeutics Inc (GALT) in total and bought 3,500 shares, with a net sale of 21,500 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 16,898 shares were bought by its insiders, resulting in a net sale of 8,102 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Harold H. Shlevin Mailing Address
Above is the net worth, insider trading, and ownership report for Harold H. Shlevin. You might contact Harold H. Shlevin via mailing address: C/o Galectin Therapeutics, Inc., 4690 Peachtree Industrial Blvd, Ste. 240, Norcross Ga 30071.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
